Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer
Open Access
- 23 May 2008
- journal article
- clinical trial
- Published by Elsevier in Laboratory Investigation
- Vol. 21 (8), 950-960
- https://doi.org/10.1038/modpathol.2008.71
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sputum Cytologic Atypia Predicts Incident Lung Cancer: Defining Latency and Histologic SpecificityCancer Epidemiology, Biomarkers & Prevention, 2008
- Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer riskInternational Journal of Cancer, 2007
- Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessmentThorax, 2007
- Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung CancerClinical Cancer Research, 2007
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningNew England Journal of Medicine, 2006
- Histological types and significance of bronchial epithelial dysplasiaLaboratory Investigation, 2006
- Surfactant Protein A Gene Deletion and Prognostics for Patients with Stage I Non–Small Cell Lung CancerClinical Cancer Research, 2005
- CT Screening for Lung Cancer: Five-year Prospective ExperienceRadiology, 2005
- Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancerCancer Detection Prevention, 2004
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002